| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.0027 | 0.9 |